Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "C01DX" (21)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Molsidomine (C01DX12) 10 products
WHO-DDD
DrugBank.ca
IP
CI
Corvaton
30 Tablet(s)
2.71
12.20
10 %
Tablets: Molsidominum 2 mg
Cheplapharm Schweiz
GmbH
B / SL
FB
G
IP
CI
Corvaton
100 Tablet(s)
6.24
16.00
10 %
Tablets: Molsidominum 2 mg
Cheplapharm Schweiz
GmbH
B / SL
FB
G
IP
CI
Corvaton forte
-
T
30 Tablet(s)
2.96
12.45
10 %
Tablets: Molsidominum 4 mg
Cheplapharm Schweiz
GmbH
B / SL
FB
G
IP
CI
Corvaton forte
-
T
100 Tablet(s)
8.44
25.60
10 %
Tablets: Molsidominum 4 mg
Cheplapharm Schweiz
GmbH
B / SL
FB
G
IP
CI
Corvaton retard
‐
I
-
T
30 Tablet(s)
3.50
13.05
10 %
comprimés à libération prolongée: Molsidominum 8 mg
Cheplapharm Schweiz
GmbH
●
B / SL
FB
G
IP
CI
Corvaton retard
‐
I
-
T
100 Tablet(s)
10.92
28.30
10 %
comprimés à libération prolongée: Molsidominum 8 mg
Cheplapharm Schweiz
GmbH
●
B / SL
FB
G
Corsifar 8 retard
30 Tablet(s)
PR
PR
k.A.
Delayed release tablets: Molsidominum 8 mg
Siphar SA
B
FB
G
Corsifar 8 retard
100 Tablet(s)
PR
PR
k.A.
Delayed release tablets: Molsidominum 8 mg
Siphar SA
B
FB
G
IP
CI
Molsidomin-Mepha 8 retard
30 Tablet(s)
9.01
20.85
k.A.
Delayed release tablets: Molsidominum 8 mg
Mepha Pharma AG
B
FB
G
IP
CI
Molsidomin-Mepha 8 retard
100 Tablet(s)
28.43
49.85
k.A.
Delayed release tablets: Molsidominum 8 mg
Mepha Pharma AG
B
FB
G
Nicorandil (C01DX16) 4 products
WHO-DDD
DrugBank.ca
IP
CI
Nicorandil Rivopharm 10 mg
30
3.94
13.50
10 %
Tablets: Nicorandilum 10 mg
Rivopharm SA
B / SL / SG
FB
G
IP
CI
Nicorandil Rivopharm 10 mg
60
6.98
16.85
10 %
Tablets: Nicorandilum 10 mg
Rivopharm SA
B / SL / SG
FB
G
IP
CI
Nicorandil Rivopharm 20 mg
30
6.47
16.25
10 %
Tablets: Nicorandilum 20 mg
Rivopharm SA
B / SL / SG
FB
G
IP
CI
Nicorandil Rivopharm 20 mg
60
11.42
28.85
10 %
Tablets: Nicorandilum 20 mg
Rivopharm SA
B / SL / SG
FB
G
Vericiguat (C01DX22) 7 products
WHO-DDD
L
IP
CI
Verquvo 2.5 mg
14
34.89
54.35
10 %
Coated tablets: Vericiguatum 2.5 mg
Bayer (Schweiz) AG
B / SL
FB
G
L
IP
Verquvo 5.0 mg
14
34.89
54.35
10 %
Coated tablets: Vericiguatum 5 mg
Bayer (Schweiz) AG
B / SL
FB
G
L
IP
Verquvo 5.0 mg
98
244.23
282.05
10 %
Coated tablets: Vericiguatum 5 mg
Bayer (Schweiz) AG
B / SL
FB
G
L
IP
Verquvo 10.0 mg
14
34.89
54.35
10 %
Coated tablets: Vericiguatum 10 mg
Bayer (Schweiz) AG
B / SL
FB
G
L
IP
Verquvo 10.0 mg
98
244.23
282.05
10 %
Coated tablets: Vericiguatum 10 mg
Bayer (Schweiz) AG
B / SL
FB
G
IP
Verquvo 5.0 mg
28
PR
PR
k.A.
Coated tablets: Vericiguatum 5 mg
Bayer (Schweiz) AG
B
FB
G
IP
Verquvo 10.0 mg
28
PR
PR
k.A.
Coated tablets: Vericiguatum 10 mg
Bayer (Schweiz) AG
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
